BIODESIX INC — Director's Dealing 2024

Mar 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2024-02-21

Reporting Person: O'Kane Kieran (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-21	Stock Options (Right to buy)	$1.46	A	35307	Acquired	2034-02-20	Common Stock (35307)	Direct

Footnotes

F1: This option vested in full on February 21, 2024. Under the Issuer's 2023 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2023 in the form of a fully-vested option.